Abdelaziz Beqqali1, Ilse A E Bollen2, Torsten B Rasmussen3, Maarten M van den Hoogenhof4, Hanneke W M van Deutekom4, Sebastian Schafer5, Jan Haas6, Benjamin Meder6, Keld E Sørensen3, Ralph J van Oort4, Jens Mogensen7, Norbert Hubner8, Esther E Creemers4, Jolanda van der Velden2, Yigal M Pinto4. 1. Department of Experimental Cardiology, Academic Medical Center, Meibergdreef 15, 1105AZ, Amsterdam, The Netherlands a.beqqali@icloud.com. 2. Department of Physiology, VU University Medical Center, Institute for Cardiovascular Research (ICaR-VU), van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands. 3. Department of Cardiology, Aarhus University Hospital, Norrebrogade 44, DK-8000, Aarhus, Denmark. 4. Department of Experimental Cardiology, Academic Medical Center, Meibergdreef 15, 1105AZ, Amsterdam, The Netherlands. 5. National Heart Research Institute Singapore, National Heart Centre Singapore, 5 Hospital Drive, Singapore 169609, Singapore Division of Cardiovascular & Metabolic Disorders, Duke-National University of Singapore, 8 College Road, Singapore 169857, Singapore. 6. Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, 69120 Heidelberg, Germany DZHK (German Centre for Cardiovascular Research), Oudenarder Straße 16, 13347 Berlin, Germany. 7. Department of Cardiology, Odense University Hospital, Sdr. Boulevard 29, 5000 Odense, Denmark. 8. DZHK (German Centre for Cardiovascular Research), Oudenarder Straße 16, 13347 Berlin, Germany Charité-Universitätsmedizin, Charitéplatz 1, 10117 Berlin, Germany Cardiovascular and Metabolic Sciences, Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany.
Abstract
AIM: Mutations in the RS-domain of RNA-binding motif protein 20 (RBM20) have recently been identified to segregate with aggressive forms of familial dilated cardiomyopathy (DCM). Loss of RBM20 in rats results in missplicing of the sarcomeric gene titin (TTN). The functional and physiological consequences of RBM20 mutations outside the mutational hotspot of RBM20 have not been explored to date. In this study, we investigated the pathomechanism of DCM caused by a novel RBM20 mutation in human cardiomyocytes. METHODS AND RESULTS: We identified a family with DCM carrying a mutation (RBM20(E913K/+)) in a glutamate-rich region of RBM20. Western blot analysis of endogenous RBM20 protein revealed strongly reduced protein levels in the heart of an RBM20(E913K/+ )carrier. RNA deep-sequencing demonstrated massive inclusion of exons coding for the spring region of titin in the RBM20(E913K/+ )carrier. Titin isoform analysis revealed a dramatic shift from the less compliant N2B towards the highly compliant N2BA isoforms in RBM20(E913K/+ )heart. Moreover, an increased sarcomere resting-length was observed in single cardiomyocytes and isometric force measurements revealed an attenuated Frank-Starling mechanism (FSM), which was rescued by protein kinase A treatment. CONCLUSION: A mutation outside the mutational hotspot of RBM20 results in haploinsufficiency of RBM20. This leads to disturbed alternative splicing of TTN, resulting in a dramatic shift to highly compliant titin isoforms and an impaired FSM. These effects may contribute to the early onset, and malignant course of DCM caused by RBM20 mutations. Altogether, our results demonstrate that heterozygous loss of RBM20 suffices to profoundly impair myocyte biomechanics by its disturbance of TTN splicing. Published on behalf of the European Society of Cardiology. All rights reserved.
AIM: Mutations in the RS-domain of RNA-binding motif protein 20 (RBM20) have recently been identified to segregate with aggressive forms of familial dilated cardiomyopathy (DCM). Loss of RBM20 in rats results in missplicing of the sarcomeric gene titin (TTN). The functional and physiological consequences of RBM20 mutations outside the mutational hotspot of RBM20 have not been explored to date. In this study, we investigated the pathomechanism of DCM caused by a novel RBM20 mutation in human cardiomyocytes. METHODS AND RESULTS: We identified a family with DCM carrying a mutation (RBM20(E913K/+)) in a glutamate-rich region of RBM20. Western blot analysis of endogenous RBM20 protein revealed strongly reduced protein levels in the heart of an RBM20(E913K/+ )carrier. RNA deep-sequencing demonstrated massive inclusion of exons coding for the spring region of titin in the RBM20(E913K/+ )carrier. Titin isoform analysis revealed a dramatic shift from the less compliant N2B towards the highly compliant N2BA isoforms in RBM20(E913K/+ )heart. Moreover, an increased sarcomere resting-length was observed in single cardiomyocytes and isometric force measurements revealed an attenuated Frank-Starling mechanism (FSM), which was rescued by protein kinase A treatment. CONCLUSION: A mutation outside the mutational hotspot of RBM20 results in haploinsufficiency of RBM20. This leads to disturbed alternative splicing of TTN, resulting in a dramatic shift to highly compliant titin isoforms and an impaired FSM. These effects may contribute to the early onset, and malignant course of DCM caused by RBM20 mutations. Altogether, our results demonstrate that heterozygous loss of RBM20 suffices to profoundly impair myocyte biomechanics by its disturbance of TTN splicing. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Matteo D'Antonio; Jennifer P Nguyen; Timothy D Arthur; Hiroko Matsui; Margaret K R Donovan; Agnieszka D'Antonio-Chronowska; Kelly A Frazer Journal: PLoS Comput Biol Date: 2022-02-28 Impact factor: 4.475
Authors: Sjoerd M Verwijs; Yigal M Pinto; Diederik W D Kuster; Jolanda van der Velden; Jacqueline Limpens; Juliette C van Hattum; Saskia N van der Crabben; Ronald H Lekanne Deprez; Arthur A M Wilde; Harald T Jørstad Journal: Cardiology Date: 2021-10-27 Impact factor: 1.869
Authors: Stephanie J Nakano; John S Walker; Lori A Walker; Xiaotao Li; Yanmei Du; Shelley D Miyamoto; Carmen C Sucharov; Anastacia M Garcia; Max B Mitchell; Amrut V Ambardekar; Brian L Stauffer Journal: Am J Physiol Heart Circ Physiol Date: 2019-10-18 Impact factor: 4.733
Authors: Claire Horvat; Renee Johnson; Lien Lam; Jacob Munro; Francesco Mazzarotto; Angharad M Roberts; Daniel S Herman; Michael Parfenov; Alireza Haghighi; Barbara McDonough; Steven R DePalma; Anne M Keogh; Peter S Macdonald; Christopher S Hayward; Amy Roberts; Paul J R Barton; Leanne E Felkin; Eleni Giannoulatou; Stuart A Cook; J G Seidman; Christine E Seidman; Diane Fatkin Journal: Genet Med Date: 2018-06-11 Impact factor: 8.822
Authors: Anna Gaertner; Julia Bloebaum; Andreas Brodehl; Baerbel Klauke; Katharina Sielemann; Astrid Kassner; Henrik Fox; Michiel Morshuis; Jens Tiesmeier; Uwe Schulz; Ralph Knoell; Jan Gummert; Hendrik Milting Journal: Genes (Basel) Date: 2021-06-08 Impact factor: 4.096